Info

Stages I–II Hodgkin lymphoma

  • PET adapted ABVD
    • doxorubicin,
    • bleomycin,
    • vinblastine,
    • dacarbazine ± RT

Favorable:

ABVD × 2–4 cycles ± RT (if PET ⊖ after 2 cycles reduce chemo or RT)

Unfavorable:

  • 50 y, bulky mediastinum,

  • “B” sx,
  • ESR >50,
  • 3 nodal sites

ABVD × 4–6 + RT (stop at 4 cycles if PET ⊖ after 2 cycles)